Standards and monitoring treatment
Open Access
- 25 June 2012
- journal article
- research article
- Published by Wiley in Haemophilia
- Vol. 18 (s4) , 61-65
Abstract
Summary. Accuracy and reproducibility of laboratory measurements are important in the diagnosis and treatment of bleeding disorders. This article describes the process of establishment of international standards and some of the problems that have arisen in standardization of these measurements.Keywords
This publication has 27 references indexed in Scilit:
- Prolonged half-life and preserved enzymatic properties of factor IX selectively PEGylated on native N-glycans in the activation peptideBlood, 2011
- International comparative field study of N8 evaluating factor VIII assay performanceHaemophilia, 2011
- Hemophilia: New Protein TherapeuticsHematology-American Society Hematology Education Program, 2010
- Functional characteristics of N8, a new recombinant FVIIIHaemophilia, 2010
- Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trialAnnals of the Rheumatic Diseases, 2009
- Genetic fusion to albumin improves the pharmacokinetic properties of factor IXThrombosis and Haemostasis, 2009
- Prolonged in-vivo half-life of factor VIIa by fusion to albuminThrombosis and Haemostasis, 2008
- Neutralization of antifactor VIII inhibitors by recombinant porcine factor VIIIJournal of Thrombosis and Haemostasis, 2006
- Measurement of factor VIII activity of B-domain deleted recombinant factor VIIISeminars in Hematology, 2001
- Discrepancy between One‐stage and Two‐stage Assay of Factor VIII:CBritish Journal of Haematology, 1978